EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oncogenic Functions of Alternatively Spliced MDM2-ALT2 Isoform in Retroperitoneal Liposarcoma

Fernanda Costas C de Faria, Safiya Khurshid, Patricia Sarchet, Sayumi Tahara, Lucia Casadei, Valerie Grignol iD, Roma Karna, Sydney Rentsch, Nipin Sp, Joal D Beane, Luciano Mazzoccoli, Matias Montes iD und 6 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252413516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Fernanda Costas C de Faria und 17 weiteren Autor:innen. Beteiligte Einrichtung: The James Comprehensive Cancer Center, Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbu…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-mdm2, Liposarcoma, Alternative Splicing, Retroperitoneal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, United States Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retroperitoneal liposarcoma (RPLPS) is one of the most common histologic subtypes of soft tissue sarcoma (STS). Complete surgical resection remains the mainstay treatment, while the high rate of locoregional recurrence constitutes the predominant cause of mortality. Well-differentiated (WDLPS) and dedifferentiated (DDLPS) liposarcoma are the most frequent subtypes of RPLPS and present amplified MDM2 gene as a hallmark. However, there are few reports evaluating the role of alternatively spliced MDM2 transcripts in RPLPS. In this study, we assessed MDM2-ALT2 expression levels in a cohort of RPLPS patients and evaluated the biological functions of the MDM2-ALT2 isoform in vitro in DDLPS cell lines. Using BaseScope™ and qPCR, we demonstrated that MDM2-Full Length (MDM2-FL) and MDM2-ALT2 expression levels were upregulated in RPLPS patient-derived tissue samples compared to normal adjacent to tumor tissue (NAT). DDLPS cells overexpressing MDM2-FL or MDM2-ALT2 had higher proliferation rates and increased migration and invasion capacities, as well as increased protein levels of p-AKT, mTOR, p70S6K, MMP2, and cJun. Simultaneous overexpression of MDM2-ALT2 and AKT silencing showed that AKT inhibition impaired p-p70S6K and MMP2 protein increased levels and led to significantly decreased proliferation and migration rates compared to cells overexpressing MDM2-ALT2 only. Taken together, our data suggest that MDM2-ALT2 may promote RPLPS progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-mdm2LiposarcomaAlternative SplicingRetroperitoneal NeoplasmsProtein IsoformsCell ProliferationHumansCell Line, TumorGene Expression Regulation, NeoplasticMaleFemaleMiddle AgedCell MovementAged

Stichwörter der Autor:innen

AKTDDLPSMDM2 variantsMDM2-ALT2MDM2-Full lengthWDLPSsoft tissue sarcoma

Substanzen

Proto-Oncogene Proteins c-mdm2MDM2 protein, humanProtein Isoforms

Autor:innen und Institutionen

  • The James Comprehensive Cancer Center, Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
  • Center for Childhood Cancer Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205, USA.
  • Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Research, Columbus, OH 43210, USA.
  • Department of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.
  • Department of Biomedical Engineering, College of Engineering, The Ohio State University, Columbus, OH 43210, USA.

ORCID-Profile: Valerie Grignol, Matias Montes, Giovanni Nigita, Jennifer L Leight, Dawn S Chandler, Raphael E Pollock

Förderung

  • NCI NIH HHS
  • NIH HHS
  • United States Department of Defense
  • NIH Cancer Center Support
  • DoD
  • NIH Cancer Center

Zitieren

APA

de Faria, F. C. C., Khurshid, S., Sarchet, P., Tahara, S., Casadei, L., Grignol, V., Karna, R., Rentsch, S., Sp, N., Beane, J. D., Mazzoccoli, L., Montes, M., Nigita, G., Sharick, J. T., Leight, J. L., Calore, F., Chandler, D. S., & Pollock, R. E. (2024). Oncogenic Functions of Alternatively Spliced MDM2-ALT2 Isoform in Retroperitoneal Liposarcoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413516

Vancouver

de Faria FCC, Khurshid S, Sarchet P, Tahara S, Casadei L, Grignol V, et al. Oncogenic Functions of Alternatively Spliced MDM2-ALT2 Isoform in Retroperitoneal Liposarcoma. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413516

BibTeX
@article{deFaria2024,
  author = {de Faria, Fernanda Costas C and Khurshid, Safiya and Sarchet, Patricia and Tahara, Sayumi and Casadei, Lucia and Grignol, Valerie and Karna, Roma and Rentsch, Sydney and Sp, Nipin and Beane, Joal D and Mazzoccoli, Luciano and Montes, Matias and Nigita, Giovanni and Sharick, Joe T and Leight, Jennifer L and Calore, Federica and Chandler, Dawn S and Pollock, Raphael E},
  title = {Oncogenic Functions of Alternatively Spliced MDM2-ALT2 Isoform in Retroperitoneal Liposarcoma},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252413516}
}
Kostenlos starten →